Knoll Capital Management, LLC Diversified Active

CIK: 0001325083 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Feb 14, 2020

Total Value ($000): $135,430 (100.0% shares, 0.0% debt)

Holdings (18)

Biohaven Pharmactl Hldg Co L 34.4%
Value ($000) $46,631 Shares 857,494 Est. Cost $27.10 Unrealized
Corbus Pharmaceuticals HLDGS 20.3%
Value ($000) $27,550 Shares 5,045,870 Est. Cost $4.99 Unrealized
Applied Therapeutics Inc 9.4%
Value ($000) $12,742 Shares 467,071 Est. Cost $8.24 Unrealized
Abeona Therapeutics Inc 6.9%
Value ($000) $9,351 Shares 2,859,767 Est. Cost $4.67 Unrealized
Blackstone Group LP 6.3%
Value ($000) $8,522 Shares 153,000 Est. Cost $34.97 Unrealized
Eiger Biopharmaceuticals Inc 3.9%
Value ($000) $5,219 Shares 350,238 Est. Cost $10.44 Unrealized
Exicure Inc 2.7%
Value ($000) $3,654 Shares 1,277,777 Est. Cost $2.86 Unrealized
ENTX Entera Bio Ltd 2.7%
Value ($000) $3,605 Shares 1,741,363 Est. Cost $3.39 Unrealized -32.1%
ALDX Aldeyra Therapeutics Inc 2.4%
Value ($000) $3,308 Shares 569,405 Est. Cost $8.37 Unrealized -31.0%
KBA Kraneshares TR 2.3%
Value ($000) $3,138 Shares 96,000 Est. Cost $31.89 Unrealized
Centurylink Inc 2.1%
Value ($000) $2,906 Shares 220,000 Est. Cost $12.48 Unrealized
AVXL Anavex Life Sciences Corp 1.4%
Value ($000) $1,876 Shares 724,205 Est. Cost $3.56 Unrealized -26.3%
DOW Dow Inc 1.2%
Value ($000) $1,642 Shares 30,000 Est. Cost $36.37 Unrealized +0.9%
Molecular Templates 1.2%
Value ($000) $1,592 Shares 113,905 Est. Cost $4.04 Unrealized
Soligenix Inc. 0.8%
Value ($000) $1,142 Shares 787,830 Est. Cost $2.11 Unrealized
DD Dupont de Nemours Inc 0.7%
Value ($000) $963 Shares 15,000 Est. Cost $27.24 Unrealized -10.0%
CTVA Corteva Inc 0.7%
Value ($000) $887 Shares 30,000 Est. Cost $25.02 Unrealized -2.1%
Catasys Inc 0.5%
Value ($000) $702 Shares 43,034 Est. Cost $16.93 Unrealized